Quarterly report pursuant to Section 13 or 15(d)

Nature of Operations

v3.8.0.1
Nature of Operations
3 Months Ended
Mar. 31, 2018
Nature of Operations  
Nature of Operations

1.Nature of Operations

 

We were incorporated in the state of Delaware on June 14, 1996. We are a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases.